FBRX Forte Biosciences, Inc. - Common Stock
$76,93
Prezzo · Ago 19, 2026
Fondamentali al Ago 12, 2026
Intervallo 52 sett.
$10–$77
100% of range
Rating Analisti
HOLD
11 analysts
Prezzo Obiettivo
$74
P/E (TTM)
-16.3
ROE
-86.9%
Margine di Profitto Netto
-2555.2%
FBRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$76.93
Capitalizzazione di Mercato
$996M
P/E (TTM)
-16.3
EPS (TTM)
$-4.71
Ricavi (TTM)
—
Rendimento div.
—
ROE
-86.9%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$10 – $77
FBRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
2016-12-31
→
2019-12-31
EPS
$-4.71
2021-12-31
→
2025-12-31
Flusso di cassa libero
$-51M
2017-12-31
→
2025-12-31
Margini
-2555.2%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
FBRX
Mediana dei peer
P/E (TTM)
-16.3
—
P/S (TTM)
55.2
22.4
P/B
16.3
2.7
Price / FCF (Prezzo / FCF)
-19.5
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
FBRX
Mediana dei peer
Operating Margin (Margine Operativo)
-2602.5%
—
Net Profit Margin (Margine di Profitto Netto)
-2555.2%
-638.9%
ROA
-96.1%
-43.1%
ROE
-86.9%
-49.0%
ROIC
-117.6%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
FBRX
Mediana dei peer
Current Ratio (Rapporto corrente)
3.9
9.0
Quick Ratio
3.7
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
FBRX
Mediana dei peer
Revenue YoY (Ricavi YoY)
106.6%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
155.9%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
FBRX
Mediana dei peer
FBRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
11 analisti
- Acquisto forte 2 18,2%
- Compra 4 36,4%
- Mantieni 5 45,5%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
5 analisti · 2026-08-13
Mediana
$77.00
Media
$73.80
Ora
$76.93
Basso
$61.00
Alto
$77.00
Target mediano
$77.00
+0,1%
Target medio
$73.80
-4,1%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.07%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.97 | $-0.90 | -0.07% |
| 31 Marzo 2026 | $-1.24 | $-1.22 | -0.02% |
| 31 Dicembre 2025 | $-1.39 | $-1.24 | -0.15% |
| 30 Settembre 2025 | $-0.99 | $-1.09 | 0.10% |
| 30 Giugno 2025 | $-0.96 | $-1.13 | 0.17% |
| 31 Marzo 2025 | $-1.37 | $-0.97 | -0.40% |
| 31 Dicembre 2024 | $-2.45 | $-3.34 | 0.89% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| TRAX | — | — | — | — | — | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $36.0K | $18M | $41.0K | $49.0K | |
| R&D Expense | · | · | · | · | · | · | $45M | $51M | $29M | $27M | |
| SG&A Expense | $12M | $15M | $11M | $8M | $8M | $4M | $1M | $13M | $9M | $5M | |
| Operating Expenses | $71M | $37M | $32M | $14M | $21M | $46M | $4M | $64M | $38M | $32M | |
| Operating Income | $-71M | $-37M | $-32M | $-14M | $-21M | $-46M | $-4M | $-46M | $-38M | $-32M | |
| Other Non-op | $-396.0K | $-190.0K | $-114.0K | $-145.0K | $-222.0K | $-205.0K | $-5.0K | · | $-1M | $-2M | |
| Pretax Income | $-68M | $-35M | $-31M | · | · | · | $-64M | $-47M | $-39M | $-33M | |
| Income Tax | $1M | $0 | · | · | · | · | $1.0K | $2M | $1.0K | $1.0K | |
| Net Income | $-69M | $-35M | $-31M | $-14M | $-22M | $-46M | $-4M | $-49M | $-39M | $-33M | |
| EPS (Basic) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | · | · | · | · | · | |
| EPS (Diluted) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 17,383,531 | 13,967,818 | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | 17,383,531 | 13,967,818 | · | · | · | · | · | |
| EBITDA | $-71M | $-37M | · | · | $-21M | $-46M | · | $-46M | $-38M | · |
Stato Patrimoniale 23
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $22M | $37M | $41M | $42M | $59M | $7M | $41M | $36M | $6M | |
| Short-term Investments | $0 | $36M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $3M | $1M | $411.0K | $476.0K | $1M | $567.0K | $2M | $2M | $1M | |
| Current Assets | $81M | $61M | $38M | $42M | $43M | $60M | $8M | $98M | $91M | $32M | |
| PP&E (Net) | $129.0K | $77.0K | $109.0K | · | · | $97.0K | $152.0K | $4M | $1M | $743.0K | |
| PP&E (Gross) | $241.0K | $125.0K | $118.0K | · | · | · | $3M | $7M | $4M | $3M | |
| Accum. Depreciation | $112.0K | $48.0K | $9.0K | · | · | · | $2M | $3M | $3M | $2M | |
| Other Non-current Assets | $2M | $138.0K | $544.0K | $486.0K | $786.0K | $1M | $0 | $1M | $227.0K | $2M | |
| Total Assets | $83M | $62M | $39M | $42M | $43M | $61M | $8M | $103M | $92M | $35M | |
| Accounts Payable | $10M | $5M | $1M | $1M | $946.0K | $1M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $11M | $4M | $2M | $2M | $812.0K | $1M | $343.0K | $13M | $8M | $5M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | $7M | $7M | |
| Current Liabilities | $21M | $9M | $4M | $3M | $2M | $2M | $2M | $17M | $17M | $14M | |
| Capital Leases | · | · | · | · | · | · | $4M | · | · | · | |
| Other Non-current Liabilities | $1M | · | · | · | · | · | $81.0K | · | · | · | |
| Total Liabilities | $22M | $9M | · | · | · | · | $17M | $45M | $21M | $28M | |
| Total Debt | · | · | · | · | · | · | · | $26M | $11M | · | |
| Common Stock | $13.0K | $6.0K | $1.0K | $21.0K | $15.0K | $13.0K | $2.0K | $23.0K | $20.0K | $2.0K | |
| Retained Earnings | $-223M | $-154M | $-119M | $-87M | $-73M | $-51M | $-5M | $-216M | $-167M | $-128M | |
| AOCI | $3.0K | $11.0K | $4.0K | · | · | · | $10.0K | $-23.0K | $-34.0K | · | |
| Stockholders' Equity | $61M | $52M | $35M | $39M | $42M | $59M | $-5M | $-736.0K | $71M | $-124M | |
| Liabilities + Equity | $83M | $62M | $39M | $42M | $43M | $61M | $8M | $103M | $92M | $35M | |
| Shares Outstanding | 12,948,308 | 6,393,323 | 1,453,402 | 21,000,069 | 14,754,447 | 12,830,598 | 2,108,266 | 23,000,151 | 19,882,551 | 2,202,517 |
Flusso di cassa 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $3M | $3M | $4M | $4M | $956.0K | $36.0K | $7M | $4M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | |
| Operating Cash Flow | $-51M | $-31M | $-29M | $-8M | $-17M | $-18M | $-3M | $-34M | $-31M | $-30M | |
| CapEx | $116.0K | $37.0K | $88.0K | · | · | · | $162.0K | $2M | $655.0K | $525.0K | |
| Investing Cash Flow | $36M | $-36M | $47.0K | · | · | $4M | $-162.0K | $-4M | $-28M | $25M | |
| Stock Issued | $2M | $0 | · | $7M | · | $67M | $551.0K | $661.0K | $507.0K | $10.0K | |
| Net Stock Activity | $2M | · | · | · | · | $67M | · | $661.0K | $507.0K | · | |
| Financing Cash Flow | $69M | $52M | $25M | $7M | $-44.0K | $67M | $5M | $44M | $89M | $2M | |
| Net Change in Cash | $55M | $-15M | $-4M | $-944.0K | $-17M | $52M | $2M | $5M | $30M | $-3M | |
| Free Cash Flow | $-51M | $-31M | · | · | · | · | · | $-36M | $-32M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2602.5% | -2785.5% | · | · | · | · | · | -254.2% | · | · | |
| Net Margin | -2555.2% | -2700.0% | · | · | · | · | · | -271.4% | · | · | |
| Pretax Margin | -2517.1% | -2700.0% | · | · | · | · | · | -262.0% | · | · | |
| EBITDA Margin | -2602.5% | -2785.5% | · | · | · | · | · | -254.2% | · | · | |
| ROA | -96.1% | -70.6% | · | · | -41.5% | -134.9% | · | -50.2% | -61.1% | · | |
| ROE | -86.9% | -114.7% | · | · | -51.0% | -117.2% | · | -92.5% | 146.0% | · | |
| ROIC | -117.6% | · | · | · | · | · | · | -56.3% | · | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 6.8 | · | · | 24.2 | 26.5 | · | 5.9 | 5.2 | · | |
| Quick Ratio | 3.7 | 6.4 | · | · | 23.9 | 26.0 | · | 2.5 | 2.1 | · | |
| Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.2 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.5 | 0.1 | · |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | 0.2 | · | · |
Tassi di Crescita 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 106.6% | 16.9% | 593.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 155.9% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $18M | $18M | $18M | $18M | $18M | $36.0K | $18M | $41.0K | · | |
| Net Income TTM | $-69M | $-35M | $-31M | $-14M | $-22M | $-46M | $-4M | $-49M | $-39M | · | |
| Market Cap | $353M | $145M | · | · | $789M | $11.68B | · | $70.81B | $76.42B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $70.80B | $76.40B | · | |
| P/E | -5.8 | -1.9 | -0.8 | -31.2 | -34.5 | · | · | · | · | · | |
| P/S | 19.6 | 8.1 | · | · | 43.8 | 647.5 | · | 3926.1 | 1863989.2 | · | |
| P/B | 5.8 | 2.8 | · | · | 19.0 | 198.0 | · | 1217.8 | 1075.1 | · | |
| P / Tangible Book | 5.8 | 2.8 | 21.1 | 13.5 | 19.0 | 198.0 | · | · | · | · | |
| P / Cash Flow | -6.9 | -4.7 | · | · | -47.3 | -633.9 | · | -2054.4 | -2454.7 | · | |
| P / FCF | -6.9 | -4.7 | · | · | · | · | · | -1943.4 | -2404.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -1544.0 | -2030.3 | · | |
| EV / FCF | · | · | · | · | · | · | · | -1943.0 | -2403.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 3925.3 | 1863376.8 | · | |
| Earnings Yield | -17.3% | -53.6% | -121.3% | -3.2% | -2.9% | · | · | · | · | · |
Conto Economico 12
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $7M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $25M | $22M | $25M | $18M | $12M | $16M | $7M | $9M | $13M | $8M | $6M | $10M | $9M | $7M | $5M | $3M | |
| Operating Income | $-25M | $-22M | $-25M | $-18M | $-12M | $-16M | $-7M | $-9M | $-13M | $-8M | $-6M | $-10M | $-9M | $-7M | $-5M | $-3M | |
| Other Non-op | $1M | $676.0K | $-2M | $701.0K | $330.0K | $468.0K | $-1M | $237.0K | $307.0K | $384.0K | $-615.0K | $261.0K | $138.0K | $102.0K | $-100.0K | $23.0K | |
| Pretax Income | $-23M | $-22M | · | · | $-11M | $-16M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $193.0K | $373.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-23M | $-22M | $-25M | $-18M | $-11M | $-16M | $-7M | $-8M | $-13M | $-7M | $-6M | $-10M | $-9M | $-7M | $-5M | $-3M | |
| EPS (Basic) | $-0.97 | $-1.24 | $-1.39 | $-0.99 | $-0.96 | $-1.37 | $3.18 | $-4.54 | $-6.78 | $-4.03 | $-17.61 | $-6.57 | $-0.42 | $-0.32 | $-0.24 | $-0.18 | |
| EPS (Diluted) | $-0.97 | $-1.24 | $-1.39 | $-0.99 | $-0.96 | $-1.37 | $3.18 | $-4.54 | $-6.78 | $-4.03 | $-17.61 | $-6.57 | $-0.42 | $-0.32 | $-0.24 | $-0.18 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | 21,046,831 | 21,006,680 | · | 18,927,446 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | 21,046,831 | 21,006,680 | · | 18,927,446 | |
| EBITDA | $-25M | $-22M | · | $-18M | $-12M | $-16M | · | $-9M | $-13M | $-8M | · | $-10M | $-9M | $-7M | · | $-3M |
Stato Patrimoniale 20
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $58M | $77M | $93M | $106M | $46M | $22M | $16M | $24M | $30M | $37M | $46M | $20M | $36M | $41M | $44M | |
| Short-term Investments | $149M | · | · | · | · | · | $36M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $7M | $4M | $2M | $1M | $1M | $3M | $1M | $1M | $1M | $1M | $917.0K | $322.0K | $369.0K | $411.0K | $546.0K | |
| Current Assets | $203M | $65M | $81M | $95M | $108M | $47M | $61M | $18M | $26M | $32M | $38M | $47M | $31M | $36M | $42M | $45M | |
| PP&E (Net) | $90.0K | $110.0K | $129.0K | $148.0K | $110.0K | $125.0K | $77.0K | $86.0K | $96.0K | $106.0K | $109.0K | $98.0K | $30.0K | · | · | · | |
| PP&E (Gross) | $241.0K | $241.0K | $241.0K | $241.0K | $186.0K | $186.0K | $125.0K | $124.0K | $124.0K | $124.0K | $118.0K | · | · | · | · | · | |
| Accum. Depreciation | $151.0K | $131.0K | $112.0K | $93.0K | $76.0K | $61.0K | $48.0K | $38.0K | $28.0K | $18.0K | $9.0K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $2M | $2M | $57.0K | $176.0K | $138.0K | $192.0K | $271.0K | $409.0K | $544.0K | $679.0K | $407.0K | $437.0K | $486.0K | $534.0K | |
| Total Assets | $206M | $67M | $83M | $97M | $108M | $47M | $62M | $18M | $26M | $32M | $39M | $48M | $31M | $37M | $42M | $45M | |
| Accounts Payable | $14M | $13M | $10M | $5M | $5M | $5M | $5M | $5M | $5M | $2M | $1M | $5M | $3M | $1M | $1M | $1M | |
| Accrued Liabilities | $6M | $11M | $11M | $8M | $4M | $4M | $4M | $3M | $4M | $2M | $2M | $2M | $3M | $2M | $2M | $1M | |
| Current Liabilities | $20M | $24M | $21M | $13M | $9M | $9M | $9M | $9M | $9M | $3M | $4M | $7M | $6M | $4M | $3M | $2M | |
| Other Non-current Liabilities | $2M | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $22M | $25M | $22M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $21.0K | $14.0K | $13.0K | $13.0K | $12.0K | $6.0K | $6.0K | $1.0K | $36.0K | $36.0K | $1.0K | $36.0K | $21.0K | $21.0K | $21.0K | $21.0K | |
| Retained Earnings | $-269M | $-246M | $-223M | $-199M | $-181M | $-170M | $-154M | $-147M | $-138M | $-126M | $-119M | $-113M | $-103M | $-94M | $-87M | $-82M | |
| AOCI | $-54.0K | $-4.0K | $3.0K | $-6.0K | · | · | $11.0K | $1.0K | $-7.0K | $-2.0K | $4.0K | $-5.0K | $1.0K | · | · | · | |
| Stockholders' Equity | $184M | $42M | $61M | $84M | $99M | $38M | $52M | $9M | $17M | $29M | $35M | $40M | $25M | $33M | $39M | $43M | |
| Liabilities + Equity | $206M | $67M | $83M | $97M | $108M | $47M | $62M | $18M | $26M | $32M | $39M | $48M | $31M | $37M | $42M | $45M | |
| Shares Outstanding | 20,482,400 | 13,910,668 | 12,948,308 | 12,523,845 | 12,282,024 | 6,581,667 | 6,393,323 | 1,460,007 | 36,442,380 | 36,394,882 | 1,453,402 | 36,281,772 | 21,051,195 | 21,007,069 | 21,000,069 | 21,000,069 |
Flusso di cassa 9
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $2M | $1M | $1M | $2M | $697.0K | $791.0K | $802.0K | $805.0K | $780.0K | $772.0K | $855.0K | $877.0K | $860.0K | $906.0K | |
| Operating Cash Flow | $-23M | $-19M | $-16M | $-14M | $-10M | $-10M | $-10M | $-8M | $-6M | $-7M | $-9M | $-9M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $0 | $0 | $0 | $55.0K | $0 | $61.0K | $31.0K | $0 | $0 | $6.0K | $17.0K | · | · | · | · | · | |
| Investing Cash Flow | $-148M | $0 | $0 | $-55.0K | $0 | $36M | $-36M | $0 | $0 | $-6.0K | $-16.0K | $10M | · | · | · | · | |
| Stock Issued | · | · | $0 | $-73M | · | · | · | · | $0 | $8.0K | · | $25M | $0 | $6.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $8.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $162M | $74.0K | $9.0K | $1M | $70M | $-2M | $52M | $-2.0K | $-10.0K | $-8.0K | $-75.0K | $25M | $-24.0K | $6.0K | $-55.0K | $7M | |
| Net Change in Cash | $-9M | $-19M | $-16M | $-13M | $60M | $24M | $6M | $-8M | $-6M | $-7M | $-9M | $26M | $-15M | $-5M | $-3M | $6M | |
| Free Cash Flow | · | $-19M | · | · | · | $-10M | · | · | · | $-7M | · | · | · | · | · | · |
Redditività 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.9% | -38.6% | · | -30.7% | -16.8% | -39.4% | · | -25.5% | -43.7% | -21.6% | · | -21.4% | -25.1% | -17.3% | · | -7.3% | |
| ROE | -16.5% | -55.0% | · | -37.8% | -19.5% | -46.7% | · | -33.7% | -59.8% | -24.1% | · | -23.9% | -28.2% | -18.5% | · | -7.9% | |
| ROIC | -13.5% | -54.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 2.8 | · | 7.3 | 11.7 | 5.2 | · | 2.1 | 2.8 | 9.5 | · | 6.3 | 4.9 | 9.6 | · | 19.4 | |
| Quick Ratio | 9.8 | 2.5 | · | 7.2 | 11.6 | 5.1 | · | 1.9 | 2.7 | 9.1 | · | 6.2 | 3.2 | 9.5 | · | 19.2 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | |
| Net Income TTM | $-74M | $-67M | · | $-53M | $-48M | $-44M | · | $-38M | $-39M | $-33M | · | $-29M | $-22M | $-16M | · | $-17M | |
| Market Cap | $435M | $360M | · | $188M | $159M | $51M | · | $8M | $489M | $633M | · | $600M | $547M | $530M | · | $562M | |
| P/E | -5.1 | -5.7 | · | -1.9 | -0.9 | -0.5 | · | -0.3 | -0.8 | -1.5 | · | -2.2 | -23.0 | -28.7 | · | -24.3 | |
| P/S | 24.1 | 20.0 | · | 10.4 | 8.8 | 2.8 | · | 0.5 | 27.1 | 35.1 | · | 33.3 | 30.3 | 29.4 | · | 31.1 | |
| P/B | 2.4 | 8.6 | · | 2.2 | 1.6 | 1.3 | · | 0.9 | 28.8 | 22.1 | · | 14.9 | 22.0 | 16.1 | · | 13.1 | |
| P / Tangible Book | 2.4 | 8.6 | · | 2.2 | 1.6 | 1.3 | · | 0.9 | 28.8 | 22.1 | · | 14.9 | 22.0 | 16.1 | · | 13.1 | |
| P / Cash Flow | · | -19.2 | · | · | · | -4.9 | · | · | · | -95.0 | · | · | · | -101.9 | · | · | |
| P / FCF | · | -19.2 | · | · | · | -4.9 | · | · | · | -94.9 | · | · | · | · | · | · | |
| Earnings Yield | -19.6% | -17.6% | · | -52.4% | -105.6% | -215.5% | · | -392.1% | -132.6% | -65.2% | · | -45.3% | -4.3% | -3.5% | · | -4.1% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margine Operativo % | -2602.5% | -2785.5% | — | — | — |
| Utile netto | $-69M | $-35M | $-31M | $-14M | $-22M |
| EPS Diluito | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 3.9 | 6.8 | — | — | 24.2 |
| Quick Ratio | 3.7 | 6.4 | — | — | 23.9 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-51M | $-31M | — | — | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 91 filer · $409.8M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 34 (+15 vs trimestre precedente) | 13 (+6 vs trimestre precedente) | 30 (+13 vs trimestre precedente) | 16 (-4 vs trimestre precedente) | +5.5M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $44.848.465 | 2.110.516 | 10,94% | Azioni |
| ORBIMED ADVISORS LLC | $33.526.231 | 1.577.705 | 8,18% | Azioni |
| JANUS HENDERSON GROUP PLC | $30.812.336 | 1.188.060 | 7,52% | Azioni |
| FRED ALGER MANAGEMENT, LLC | $30.593.561 | 1.439.697 | 7,47% | Azioni |
| Affinity Asset Advisors, LLC | $24.339.559 | 1.145.391 | 5,94% | Azioni |
| MPM BIOIMPACT LLC | $20.983.270 | 987.448 | 5,12% | Azioni |
| TCG Crossover Management, LLC | $19.550.000 | 920.000 | 4,77% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.311.911 | 861.737 | 4,47% | Azioni |
| Woodline Partners LP | $15.146.001 | 712.753 | 3,70% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $14.875.000 | 700.000 | 3,63% | Azioni |
| Integral Health Asset Management, LLC | $14.343.750 | 675.000 | 3,50% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $13.922.979 | 655.199 | 3,40% | Azioni |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $11.799.705 | 786.647 | 2,88% | Azioni |
| CITADEL ADVISORS LLC | $11.388.789 | 535.943 | 2,78% | Azioni |
| FMR LLC | $10.685.053 | 502.826 | 2,61% | Azioni |
| AMERIPRISE FINANCIAL INC | $8.898.586 | 418.757 | 2,17% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $8.502.392 | 400.003 | 2,07% | Azioni |
| Cable Car Capital, LP | $8.500.000 | 400.000 | 2,07% | Azioni |
| STATE STREET CORP | $6.981.093 | 328.522 | 1,70% | Azioni |
| Candriam S.C.A. | $6.434.678 | 303.100 | 1,57% | Azioni |
| Boxer Capital Management, LLC | $5.833.125 | 274.500 | 1,42% | Azioni |
| Trails Edge Capital Partners, LP | $5.805.097 | 273.181 | 1,42% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $5.305.976 | 249.693 | 1,29% | Azioni |
| Squadron Capital Management LLC | $4.781.250 | 225.000 | 1,17% | Azioni |
| AWM Investment Company, Inc. | $4.728.125 | 222.500 | 1,15% | Azioni |
| UBS Group AG | $3.463.198 | 162.974 | 0,85% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.893.698 | 136.174 | 0,71% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.842.634 | 133.771 | 0,69% | Azioni |
| Nuveen, LLC | $2.302.374 | 108.347 | 0,56% | Azioni |
| VANGUARD GROUP INC | $1.842.770 | 67.575 | 0,45% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.797.750 | 84.600 | 0,44% | Opzione Put |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $999.664 | 47.043 | 0,24% | Azioni |
| J. Goldman & Co LP | $981.368 | 46.182 | 0,24% | Azioni |
| Balyasny Asset Management L.P. | $826.583 | 38.898 | 0,20% | Azioni |
| MANGROVE PARTNERS IM, LLC | $708.603 | 33.346 | 0,17% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $639.795 | 30.108 | 0,16% | Azioni |
| XTX Topco Ltd | $636.374 | 29.947 | 0,16% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $559.470 | 26.328 | 0,14% | Azioni |
| Trexquant Investment LP | $534.820 | 25.168 | 0,13% | Azioni |
| Weil Company, Inc. | $526.256 | 24.765 | 0,13% | Azioni |
| AlphaQuest LLC | $512.785 | 18.804 | 0,13% | Azioni |
| RHUMBLINE ADVISERS | $470.662 | 22.149 | 0,11% | Azioni |
| Ikarian Capital, LLC | $445.655 | 20.972 | 0,11% | Azioni |
| JANE STREET GROUP, LLC | $418.370 | 19.688 | 0,10% | Azioni |
| Persistent Asset Partners Ltd | $388.089 | 18.263 | 0,09% | Azioni |
| WELLS FARGO & COMPANY/MN | $375.360 | 17.664 | 0,09% | Azioni |
| Russell Investments Group, Ltd. | $349.180 | 16.432 | 0,09% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $346.162 | 16.290 | 0,08% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304.109 | 14.311 | 0,07% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $293.250 | 13.800 | 0,07% | Opzione Call |
| TWO SIGMA INVESTMENTS, LP | $284.984 | 13.411 | 0,07% | Azioni |
| Squarepoint Ops LLC | $261.736 | 12.317 | 0,06% | Azioni |
| BANK OF AMERICA CORP /DE/ | $251.345 | 11.828 | 0,06% | Azioni |
| MetLife Investment Management, LLC | $243.759 | 11.471 | 0,06% | Azioni |
| Bank of New York Mellon Corp | $237.958 | 11.198 | 0,06% | Azioni |
| GOLDMAN SACHS GROUP INC | $236.576 | 11.133 | 0,06% | Azioni |
| BlackRock, Inc. | $218.153 | 10.266 | 0,05% | Azioni |
| ExodusPoint Capital Management, LP | $217.239 | 10.223 | 0,05% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $188.700 | 8.880 | 0,05% | Azioni |
| China Universal Asset Management Co., Ltd. | $170.000 | 8.000 | 0,04% | Azioni |
| CITIGROUP INC | $169.660 | 7.984 | 0,04% | Azioni |
| Invesco Ltd. | $164.114 | 7.723 | 0,04% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $144.500 | 6.800 | 0,04% | Azioni |
| Vanguard Global Advisers, LLC | $142.418 | 6.702 | 0,03% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $121.380 | 5.712 | 0,03% | Azioni |
| NORTHERN TRUST CORP | $64.558 | 3.038 | 0,02% | Azioni |
| BARCLAYS PLC | $58.438 | 2.750 | 0,01% | Azioni |
| Tower Research Capital LLC (TRC) | $45.475 | 2.140 | 0,01% | Azioni |
| Legal & General Group Plc | $39.950 | 1.880 | 0,01% | Azioni |
| Ameritas Investment Partners, Inc. | $37.358 | 1.758 | 0,01% | Azioni |
| STRS OHIO | $36.125 | 1.700 | 0,01% | Azioni |
| Quantbot Technologies LP | $30.685 | 1.444 | 0,01% | Azioni |
| State of Wyoming | $21.675 | 1.020 | 0,01% | Azioni |
| ROYAL BANK OF CANADA | $16.000 | 748 | 0,00% | Azioni |
| NATIONAL BANK OF CANADA /FI/ | $12.155 | 572 | 0,00% | Azioni |
| Steward Partners Investment Advisory, LLC | $10.476 | 493 | 0,00% | Azioni |
| DEUTSCHE BANK AG\ | $7.884 | 371 | 0,00% | Azioni |
| LORD, ABBETT & CO. LLC | $4.472 | 210.442 | 0,00% | Azioni |
| COMERICA BANK | $4.091 | 150 | 0,00% | Azioni |
| FIFTH THIRD BANCORP | $3.188 | 150 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $2.401 | 113 | 0,00% | Azioni |
| GROUP ONE TRADING LLC | $2.210 | 104 | 0,00% | Azioni |
| Sterling Capital Management LLC | $1.445 | 68 | 0,00% | Azioni |
| MORGAN STANLEY | $829 | 39 | 0,00% | Azioni |
| ASSETMARK, INC | $723 | 34 | 0,00% | Azioni |
| Quarry LP | $574 | 27 | 0,00% | Azioni |
| PRICE T ROWE ASSOCIATES INC /MD/ | $338 | 15.900 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $256 | 12 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $255 | 12 | 0,00% | Azioni |
| REAP Financial Group, LLC | $64 | 3 | 0,00% | Azioni |
| Allworth Financial LP | $22 | 1 | 0,00% | Azioni |
Insider aziendali 26 insider · 9 dirigenti · 19 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul A. Wagner | CEO, Secretary and Chair of the Board | 01 Luglio 2026 M | 85.482 | 0 | 0 | $0 |
| Martin J Duvall | Chief Executive Officer | 04 Ottobre 2019 A | 13.605 | 0 | 0 | $0 |
| Antony A Riley | CHIEF FINANCIAL OFFICER | 01 Luglio 2026 M | 42.600 | 1 | 0 | $254.874 |
| Mark G Foletta | EVP & Chief Financial Officer | 04 Ottobre 2019 A | 15.042 | 0 | 0 | $0 |
| Hubert C Chen | President and Chief Scientific Officer | 01 Gennaio 2024 M | 93.405 | 0 | 0 | $0 |
| Harry E Gruber | President, Science&Innovation | 26 Febbraio 2020 A | 23.685 | 0 | 0 | $0 |
| Fairooz Kabbinavar | SVP Clinical Development | 04 Ottobre 2019 A | — | 0 | 0 | $0 |
| Douglas Jolly | EVP, Research & Pharm Devel | 04 Ottobre 2019 A | 393.478 | 0 | 0 | $0 |
| Asha Das | SVP & Chief Medical Officer | 01 Marzo 2018 A | 5.000 | 0 | 0 | $0 |
| Shivpreet Singh Kapoor | Direttore | 29 Maggio 2026 A | — | 0 | 0 | $0 |
| Scott C. Brun | Direttore | 29 Maggio 2026 A | — | 0 | 0 | $0 |
| Steven Kornfeld | Direttore | 29 Maggio 2026 A | 99.009 | 0 | 0 | $0 |
| Stephen K Doberstein | Direttore | 29 Maggio 2026 A | — | 0 | 0 | $0 |
| Richard G Vincent | Direttore | 29 Maggio 2026 A | — | 0 | 0 | $0 |
| David W Gryska | Direttore | 29 Maggio 2026 A | 148.514 | 0 | 0 | $0 |
| Lawrence Eichenfield | Direttore | 19 Settembre 2023 A | — | 0 | 0 | $0 |
| Donald Allen Williams | Direttore | 19 Settembre 2023 A | 59.405 | 0 | 0 | $0 |
| Barbara K Finck | Direttore | 19 Settembre 2023 A | — | 0 | 0 | $0 |
| Patricia S Walker | Direttore | 01 Giugno 2022 A | — | 0 | 0 | $0 |
| Thomas E Darcy | Direttore | 13 Gennaio 2021 M | 2.358 | 0 | 0 | $0 |
| Lori Anne Kunkel | Direttore | 04 Ottobre 2019 A | — | 0 | 0 | $0 |
| David Ross Parkinson | Direttore | 04 Ottobre 2019 A | — | 0 | 0 | $0 |
| Faheem Hasnain | Direttore | 04 Ottobre 2019 A | 245.857 | 0 | 0 | $0 |
| Franklin M Berger | Direttore | 04 Ottobre 2019 A | 25.335 | 0 | 0 | $0 |
| SCHIMMEL PAUL | Direttore | 04 Ottobre 2019 A | 13.623 | 0 | 0 | $0 |
| Steven Michael Oliveira | Proprietario del 10% | 14 Aprile 2020 P | 2.873.450 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 6 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, Eric Shahinian, ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg, Michael G. Hacke, McIntyre Partnerships, LP, McIntyre Capital GP, LLC, McIntyre Capital Management, LP, McIntyre Capital Management GP, LLC, Chris McIntyre ×11 depositi | 17 Giugno 2024 | — | Deposito iniziale | — | SEC |
| BML Investment Partners, L.P. ×6 depositi | 11 Gennaio 2024 | — | Deposito iniziale | — | SEC |
| Funicular Funds, LP, Jacob Ma-Weaver ×6 depositi | 09 Gennaio 2024 | — | Deposito iniziale | — | SEC |
| Paul A. Wagner, Ph.D. (2) ×2 depositi | 15 Agosto 2023 | — | Deposito iniziale | — | SEC |
| ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg ×2 depositi | 10 Agosto 2023 | — | Deposito iniziale | — | SEC |
| Paul A. Wagner, Ph.D. | 25 Giugno 2020 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 13 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,34% | 65.797 SH | 08 Agosto 2026 | Giornaliero |
| SBIO · ALPS ETF Trust | 0,15% | 12.912 NS | 31 Maggio 2026 | N-PORT |
| IWO · iShares Trust | 0,09% | 177.467 SH | 08 Agosto 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 1.757 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,05% | 485.030 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 20.646 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 111.500 SH | 08 Agosto 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 30.190 SH | 08 Agosto 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 5.159 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1.062 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 217.359 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 622.927 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.625 SH | 08 Agosto 2026 | Giornaliero |